Your browser is no longer supported. Please, upgrade your browser.
Settings
GRFS Grifols, S.A. daily Stock Chart
GRFS [NASD]
Grifols, S.A.
Index- P/E36.68 EPS (ttm)0.60 Insider Own- Shs Outstand684.13M Perf Week-0.14%
Market Cap15.04B Forward P/E16.17 EPS next Y1.36 Insider Trans- Shs Float- Perf Month-0.72%
Income- PEG3.25 EPS next Q0.32 Inst Own60.84% Short Float- Perf Quarter19.84%
Sales- P/S- EPS this Y3.40% Inst Trans- Short Ratio1.35 Perf Half Y11.06%
Book/sh3.56 P/B6.18 EPS next Y12.40% ROA- Target Price22.38 Perf Year10.06%
Cash/sh- P/C- EPS next 5Y11.30% ROE- 52W Range17.42 - 23.03 Perf YTD19.77%
Dividend0.35 P/FCF- EPS past 5Y0.42% ROI- 52W High-4.52% Beta-
Dividend %1.59% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low26.23% ATR0.37
Employees22282 Current Ratio- Sales Q/Q15.40% Oper. Margin- RSI (14)55.23 Volatility1.32% 1.62%
OptionableYes Debt/Eq- EPS Q/Q-1.70% Profit Margin- Rel Volume0.44 Prev Close21.82
ShortableYes LT Debt/Eq- EarningsAug 16 BMO Payout- Avg Volume1.48M Price21.99
Recom2.00 SMA20-0.90% SMA503.70% SMA20011.39% Volume645,418 Change0.78%
Jun-27-19Upgrade JP Morgan Neutral → Overweight
Feb-08-19Downgrade Berenberg Buy → Hold
Oct-11-18Upgrade Berenberg Hold → Buy
Jun-01-18Initiated Barclays Overweight
Oct-31-17Initiated Citigroup Buy
Jun-30-17Downgrade Goldman Buy → Neutral
Apr-06-17Initiated BofA/Merrill Buy
Jan-03-17Upgrade JP Morgan Neutral → Overweight
Feb-09-16Upgrade Berenberg Hold → Buy
Jan-04-16Downgrade Morgan Stanley Equal-Weight → Underweight
Dec-02-15Downgrade HSBC Securities Buy → Hold
Nov-20-15Downgrade Berenberg Buy → Hold
Apr-28-15Downgrade Berenberg Buy → Hold
Jul-31-19 04:54AM  Is Grifols, S.A.'s (BME:GRF) 1.2% Dividend Worth Your Time? Simply Wall St.
Jul-16-19 02:39AM  Grifols presents additional encouraging Alzheimer's trial results at AAIC PR Newswire
Jul-08-19 09:22AM  Company News for Jul 8, 2019 Zacks
05:06AM  How Much Are Grifols, S.A. (BME:GRF) Insiders Spending On Buying Shares? Simply Wall St.
Jul-05-19 04:17PM  This Pharma Stock Dodged A Broad Slide For Drugmakers Here's Why Investor's Business Daily
08:55AM  The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer Treatment, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight Benzinga
Jul-04-19 11:51AM  Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies PR Newswire
Jul-03-19 05:00AM  Grifols Selected to Build Its First Intravenous Solutions Manufacturing Line in Africa PR Newswire
Jun-29-19 08:13PM  Is Grifols SA (GRFS) A Good Stock To Buy ? Insider Monkey
Jun-27-19 04:34PM  These European companies benefit from high health-care prices in the U.S. MarketWatch
Jun-19-19 09:00AM  Grifols to launch plasma-protein-based bleeding-control solutions PR Newswire
Jun-12-19 08:15AM  Is Rigel Pharmaceuticals a Buy? Motley Fool
Jun-06-19 06:39AM  Do Institutions Own Grifols, S.A. (BME:GRF) Shares? Simply Wall St.
May-20-19 06:43PM  George Soros' Top 6 New Buys of the 1st Quarter GuruFocus.com
May-09-19 09:30AM  GRFS or ORINY: Which Is the Better Value Stock Right Now? Zacks
May-08-19 12:23AM  Rigel Pharmaceuticals Inc (RIGL) Q1 2019 Earnings Call Transcript Motley Fool
Apr-30-19 06:00AM  Grifols Announces PharmacyKeeper Bidirectional Integration with Epic PR Newswire
Apr-29-19 12:00PM  Grifols Announces the Opening of its new Plasma Donor Center in Hinesville, Georgia PR Newswire
03:14AM  What Does Grifols, S.A.'s (BME:GRF) P/E Ratio Tell You? Simply Wall St.
Apr-18-19 09:00AM  Grifols US donor centers exceed 250,000 pounds of food collected PR Newswire
Apr-15-19 06:15AM  Grifols donations of blood clotting factor helping people with hemophilia globally PR Newswire
Apr-05-19 10:55AM  Grifols 2018 Annual Report on Form 20-F Filed With the SEC on April 5, 2019 PR Newswire
Apr-02-19 06:46AM  Grifols, S.A. (BME:GRF): What We Can Expect From This Growth Stock Simply Wall St.
Mar-31-19 12:17PM  Should You Buy Grifols SA (GRFS)? Insider Monkey
Mar-23-19 09:00AM  Grifols Announces the Opening of its new Plasma Donor Center in Russellville, AR PR Newswire
Mar-07-19 04:03AM  Spain's Grifols, China's Shanghai RAAS form strategic alliance Reuters
03:32AM  Blood Giant Grifols Acquires $1.9 Billion Stake in Shanghai RAAS Bloomberg
Mar-01-19 09:18AM  Rigel Pharmaceuticals (RIGL) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-21-19 11:22AM  Grifols PharmacyKeeper Receives KLAS Category Leader Award for Third Consecutive Year PR Newswire
Feb-19-19 05:54PM  'Young blood' Alzheimer's treatments slapped with warning by FDA commissioner American City Business Journals
05:30PM  East Bay biotech with late-stage drug files for bankruptcy American City Business Journals
Feb-07-19 12:31PM  Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System PR Newswire
Feb-05-19 05:29AM  What To Know Before Buying Grifols, S.A. (BME:GRF) For Its Dividend Simply Wall St.
Jan-23-19 10:20AM  Rigel Rises On European Marketing Agreement For Autoimmune Drug Benzinga
07:51AM  Rigel Pharmaceuticals stock up 9% after announcing licensing agreement with Grifols MarketWatch
07:30AM  Rigel Pharmaceuticals Enters Collaboration and License Agreement with Grifols, S.A. to Commercialize Fostamatinib in Europe PR Newswire
Jan-08-19 07:37AM  Grifols receives FDA approval of Erytra Eflexis®, the latest advancement in scalable blood typing solutions PR Newswire
Jan-06-19 02:54AM  A Note On Grifols, S.A.s (BME:GRF) ROE and Debt To Equity Simply Wall St.
Dec-07-18 01:56AM  A Look At The Fair Value Of Grifols SA (BME:GRF) Simply Wall St.
Nov-22-18 09:13AM  Shanghai RAAS in tie-up talks with U.S. blood products arm of Spain's Grifols Reuters
07:51AM  BRIEF-Shanghai RAAS Blood Products Plans To Acquire Tiancheng (Germany), Spain's Grifols Diagnostic Solutions Reuters
05:44AM  BRIEF-Shanghai RAAS Blood Products Plans To Buy Germany's Biotest, Spain's Grifols Diagnostic Solutions Reuters
Oct-27-18 03:30AM  Grifols demonstrates a significant reduction (61%) in the progression of moderate Alzheimer's disease using its AMBAR treatment protocol PR Newswire
Oct-12-18 09:50AM  FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing PR Newswire
09:17AM  Grifols (GRFS) Surges: Stock Moves 5.4% Higher Zacks
Oct-08-18 02:57PM  Grifols Delivers Promise of Advancing Plasma-derived Medicines through Innovative Vision and Donor Support PR Newswire
Oct-03-18 11:52AM  Italian stocks lead Europe as budget deficit fears quelled Reuters
Sep-26-18 08:56AM  Recent Analysis Shows Green Plains Partners LP, Companhia Paranaense de Energia (COPEL), China Yuchai International, AerCap Holdings N.V., Northwest Natural Gas, and Grifols, S.A Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Sep-24-18 12:59PM  Grifols Announces the Opening of Biotest Pharmaceuticals Corporation's Newest Plasma Donor Center in Bowling Green, Ohio PR Newswire
Sep-17-18 09:35AM  Is Grifols, S.A. (GRFS) a Great Stock for Value Investors? Zacks
Sep-11-18 07:34AM  Who Owns Grifols SA (BME:GRF)? Simply Wall St.
Sep-07-18 01:30PM  Grifols: Just-approved medicine will only be manufactured in Clayton American City Business Journals
Aug-16-18 08:00AM  Grifols Achieves Key Milestone with FDA Approval of the New Consolidated Manufacturing Facility (CMF) for Production of Recombinant Proteins PR Newswire
Aug-14-18 08:00AM  Procleix® Zika Virus Assay Approved by the FDA for Blood Screening on the Procleix® Panther® System PR Newswire
Aug-01-18 11:36AM  Healthcare firm Grifols S.A. wins US antitrust nod to buy Biotest US Corp Reuters
Jun-27-18 02:23AM  What is Behind Grifols SAs (BME:GRF) Superior ROE? Simply Wall St.
Jun-22-18 07:30AM  Free Technical Research on ImmunoGen and Three More Biotech Equities ACCESSWIRE
Jun-19-18 08:25AM  Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays PR Newswire
Jun-15-18 02:39PM  2 Stable and 2 Speculative Biotech Stocks to Buy InvestorPlace
Jun-07-18 08:15AM  Factors of Influence in 2018, Key Indicators and Opportunity within Eldorado Gold, Lamar Advertising, Bitauto, Magellan Midstream Partners, Deutsche Bank Aktiengesellschaft, and Grifols, S.A. New Research Emphasizes Economic Growth GlobeNewswire
May-31-18 09:00AM  Grifols Launches a New Testing Service for Patients Treated with Daratumumab PR Newswire
May-25-18 01:46PM  Biotech and energy top list for best paying jobs Yahoo Finance Video
May-14-18 08:00AM  Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents PR Newswire
May-10-18 03:59AM  BRIEF-Boya Bio-Pharmaceutical Signs Agreement With Grifols S.A. To Set Up Blood Plasma Stations Reuters
Apr-27-18 02:43PM  Grifols, Novo expansions prompt $1.3M renovation of JoCo training center American City Business Journals
Apr-16-18 11:21AM  Grifols donates over 25 million international units of blood clotting factor in 2017 PR Newswire
Apr-13-18 06:19AM  With 21.50% Earnings Growth, Did Grifols SA. (BME:GRF) Outperform The Industry? Simply Wall St.
Apr-10-18 08:20AM  Report: Exploring Fundamental Drivers Behind Itau Unibanco Holding S.A, Weibo, Redhill Biopharma, Shenandoah Telecommunications, Grifols, S.A, and Orthofix International N.V New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Apr-06-18 10:40AM  Grifols 2017 Annual Report on Form 20-F filed with the SEC on April 6, 2018 PR Newswire
Mar-29-18 08:59AM  Estimating The Fair Value Of Grifols SA. (BME:GRF) Simply Wall St.
Mar-22-18 08:38AM  Is It Time To Buy Grifols SA. (BME:GRF) Based Off Its PE Ratio? Simply Wall St.
Mar-15-18 06:50AM  Can Grifols SA. (BME:GRF) Continue To Outperform Its Industry? Simply Wall St.
Mar-14-18 02:50PM  Grifols breaks ground on $120M Clayton facility American City Business Journals
Mar-13-18 08:00AM  Consolidated Research: 2018 Summary Expectations for B Communications, Student Transportation, Aurinia Pharmaceuticals, Grifols, S.A., NEXEO SOLUTIONS, and ASML Holding N.V.  Fundamental Analysis, Key Performance Indications GlobeNewswire
Mar-06-18 09:42AM  Henry Schien to Distribute Grifols Product in United States Zacks
Mar-05-18 09:00AM  Grifols Announces New Agreement with Henry Schein to Distribute Normal Saline Solution in the U.S. PR Newswire
Feb-28-18 10:05AM  Grifols Shines Light on Rare Disease with Launch of Educational Campaign "Look Into Genetic COPD" PR Newswire
Feb-06-18 09:45AM  Grifols HyperRAB® (rabies immune globulin ) 300 IU/mL Receives FDA Approval to Treat Patients Exposed to Rabies Virus Infection PR Newswire
Jan-03-18 03:00AM  Stocks With Rising Relative Price Strength: Grifols Investor's Business Daily
Dec-19-17 01:09PM  ETFs with exposure to Grifols SA : December 19, 2017 Capital Cube
Dec-11-17 12:06PM  Grifols SA : GRFS-US: Dividend Analysis : December 04th, 2017 (record date) : By the numbers : December 11, 2017 Capital Cube
Dec-05-17 12:54PM  ETFs with exposure to Grifols SA : December 5, 2017 Capital Cube
Dec-04-17 08:00AM  Grifols Misterium® Cleanroom Solutions Expands to Include Revolutionary Decontamination Air and Surface Disinfection Systems for Pharmaceutical Preparation PR Newswire
Nov-16-17 11:39AM  ETFs with exposure to Grifols SA : November 16, 2017 Capital Cube
Nov-02-17 12:11PM  ETFs with exposure to Grifols SA : November 2, 2017 Capital Cube
Oct-31-17 03:00AM  Stocks Showing Rising Market Leadership: Grifols Earns 83 RS Rating Investor's Business Daily +5.35%
Oct-23-17 10:40AM  ETFs with exposure to Grifols SA : October 23, 2017 Capital Cube
Oct-10-17 11:29AM  ETFs with exposure to Grifols SA : October 10, 2017 Capital Cube
Oct-09-17 09:51AM  Grifols SA :GRFS-US: Earnings Analysis: Q2, 2017 By the Numbers : October 9, 2017 Capital Cube
Sep-20-17 09:30AM  Should Value Investors Consider Grifols (GRFS) Stock Now? Zacks
Sep-13-17 11:25AM  3 Pharma/Biotech Sector Bargains for a Healthy Portfolio Zacks
Sep-06-17 03:00AM  Grifols Shows Market Leadership With Jump To 82 RS Rating Investor's Business Daily
Aug-29-17 12:31PM  Grifols Is a Leader in High-Demand Plasma GuruFocus.com
Aug-28-17 03:00AM  Stocks Flashing Renewed Technical Strength: Grifols Investor's Business Daily
Aug-22-17 08:00AM  Grifols Phocus Rx® Pharmacy Workflow Management Solution Now Integrates With Top Hospital Information Systems via HL7 Interfaces PR Newswire
Aug-01-17 08:00AM  Select American Red Cross Blood Donations Screened for Babesia Parasite Using Grifols' Procleix Babesia Assay Under an Investigational New Drug Protocol PR Newswire
Jun-22-17 03:11PM  Grifols Continues to Strengthen its Diagnostic Division by Launching New Global Testing Services for the Measurement of Biological Drug Levels and Anti-Drug Immune Response in Blood Samples PR Newswire
Jun-21-17 03:48PM  When 'New' Means A Stock Hasn't Led The Market In A While Investor's Business Daily
Jun-16-17 09:55AM  Should Value Investors Consider Grifols (GRFS) Stock Right Now? Zacks
Jun-12-17 04:00AM  Grifols and Beckman Coulter Enter into an Exclusive Distribution Agreement PR Newswire
Grifols, S.A., a specialty pharmaceutical company, develops, manufactures, and distributes a range of biological medicines on plasma derived proteins worldwide. The company operates through five segments: Bioscience, Diagnostic, Hospital, Bio Supplies, and Others. The Bioscience segment manufactures plasma derivatives for therapeutic use; and sells and distributes end products. It offers plasma products, such as intravenous immune globulin, Factor VIII, alpha-1 proteinase inhibitor, and albumin; and intramuscular immunoglobulins, antithrombin III, Factor IX, and plasma thromboplastin components. The Diagnostic segment focuses on researching, developing, manufacturing, and marketing in vitro diagnostics products, including analytical instruments, reagents, software, and related products for use in clinical and blood bank laboratories. It serves blood donation centers, clinical analysis laboratories, and hospital immunohematology services. The Hospital segment offers products used by hospitals, as well as parenteral solutions and enteral nutritional fluids. The Bio Supplies segment provides biological products for non-therapeutic uses. The Others segment renders manufacturing services to third party companies. The company also provides infusion solutions, nutrition products, and medical devices for use in hospitals and clinics; and engineering services. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves hospitals and clinics, group purchasing organizations, governments, and other distributors through sales representatives, marketing partners, and third-party distributors. The company was founded in 1940 and is headquartered in Barcelona, Spain.